论文部分内容阅读
目的探讨疏血通注射液联合阿托伐他汀钙片治疗颈动脉粥样硬化(carotid atherosclerosis,CAS)的临床疗效及其对血脂水平的影响。方法 70例CAS患者随机分为治疗组和对照组。对照组给予阿托伐他汀钙片治疗,治疗组给予疏血通注射液联合阿托伐他汀钙片治疗,治疗6个月后评价临床疗效,测定血脂水平。结果治疗组临床疗效总有效率为94.3%,显著高于对照组(68.6%),有统计学差异(P<0.05);治疗后,治疗组TG,TC,LDL水平与治疗前、对照组比较明显降低,HDL水平明显上升,均有统计学差异(P<0.05)。结论疏血通注射液联合阿托伐他汀钙片治疗CAS临床疗效好,具有改善脂质代谢的作用,值得临床推广应用。
Objective To investigate the clinical efficacy of Shuxuetong injection combined with atorvastatin calcium in the treatment of carotid atherosclerosis (CAS) and its effect on serum lipid levels. Methods 70 CAS patients were randomly divided into treatment group and control group. Control group was given atorvastatin calcium treatment, the treatment group was given Shuxuetong injection combined with atorvastatin calcium treatment, 6 months after treatment to evaluate the clinical efficacy, determination of lipid levels. Results The total effective rate of the treatment group was 94.3%, which was significantly higher than that of the control group (68.6%) (P <0.05). After treatment, the levels of TG, TC and LDL in the treatment group were significantly lower than those in the control group Significantly lower HDL levels were significantly increased, both were statistically significant (P <0.05). Conclusion Shuxuetong injection combined with atorvastatin calcium CAS treatment of clinical efficacy, with the role of improving lipid metabolism, it is worth promoting the clinical application.